Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)

Publisher： Karger

E-ISSN： 1662-6575|10|2|420-427

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.2, 2017-05, pp. : 420-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Long-Term Safety of Everolimus in Pancreatic Neuroendocrine Tumor Associated with Multiple Endocrine Neoplasia Type I: Case Report

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 643-645

Karger

Access to resources Recommend Favorite

Long-Term Clinical Remission in a Patient with Metastatic Gastric Cancer after Palliative Chemotherapy

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 464-466

Karger

Access to resources Recommend Favorite

Long-Term Remissions in Metastatic Malignant Melanoma Following Chemotherapy and Tamoxifen Maintenance

By  

Oncology Research and Treatment, Vol. 34, Iss. 4, 2011-03 ,pp. : 208-209

Karger

Access to resources Recommend Favorite

Pilot Study of Combination Chemotherapy Using Irinotecan plus S-1 for Metastatic Pancreatic Cancer

By  

Oncology, Vol. 75, Iss. 1-2, 2008-08 ,pp. : 67-70

Karger

Access to resources Recommend Favorite

Cardiac Recurrence in a Patient with Long-Term Survival from Metastatic Colon Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-04 ,pp. : 202-207

Karger

Access to resources Recommend Favorite